Science Videos

from AP, Reuters, AFP, and other news services

Practicing on patients? Not in new doc boot camp

Date:
July 7, 2014
Source:
AP / Powered by NewsLook.com
Summary:
New doctors at a Chicago hospital can't practice on patients. The interns must first withstand a rigorous boot camp with mock baby deliveries, fake wound stitching and simulated emergencies to get them ready for the real deal. (July 7) Video provided by AP


Related Videos

last updated on 2015-04-19 at 11:42 am EDT

Bipartisan Support for Medicare 'Doc Fix'

Bipartisan Support for Medicare 'Doc Fix'

AP (Apr. 16, 2015) — At a bipartisan gathering on Capitol Hill, Republican and Democratic leaders touted the passage of the so-called "doc fix" for Medicare. (April 16) Video provided by AP
Powered by NewsLook.com
Can Ayurveda Help With Anxiety and Depression?

Can Ayurveda Help With Anxiety and Depression?

Howdini (Oct. 2, 2013) — Psychiatrist Dr. Henry Emmons describes Ayurveda and its Vata, Pitta, and Kapha body types. How can practicing Ayurveda help you live a balanced life and decrease anxiety and depression? Watch and find out.
Powered by NewsLook.com
Raw: Bolivian Grandmothers Stay Agile With Game

Raw: Bolivian Grandmothers Stay Agile With Game

AP (Feb. 24, 2015) — Dozens of traditional Aymara grandmothers ease many of the aches and pains of aging by practicing team handball, a sport that is decidedly untraditional in Bolivia. (Feb. 24) Video provided by AP
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins